CTSOVSHCA• 12 Months (Normalized)
CTSO vs HCA (Cytosorbents Corporation vs HCA Healthcare Inc.)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $4.05
+311.17%
Cytosorbents Corporation
Normalized Baseline0.00%
HCA Performance $426.69
+0%
HCA Healthcare Inc.
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
+311.17 pts
CTSO outperforming by 311.17 percentage points
CTSOHCA
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO HCA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | CTSO Price | CTSO Gain (%) | HCA Price | HCA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $4.05 | +311.17% | $426.69 | +0.00% | +311.17% |
| Sep 30, 2026 | $3.90 | +295.94% | $430.43 | +0.88% | +295.06% |
| Sep 29, 2026 | $4.00 | +306.09% | $431.63 | +1.16% | +304.93% |
| Sep 28, 2026 | $4.02 | +308.12% | $432.60 | +1.39% | +306.73% |
| Sep 25, 2026 | $4.38 | +344.67% | $435.61 | +2.09% | +342.58% |
| Sep 24, 2026 | $4.30 | +336.55% | $423.48 | -0.75% | +337.30% |
| Sep 23, 2026 | $4.91 | +398.48% | $436.48 | +2.29% | +396.19% |
| Sep 22, 2026 | $- | $438.12 | +2.68% | - | |
| Sep 21, 2026 | $5.51 | +459.39% | $425.97 | -0.17% | +459.56% |
| Sep 18, 2026 | $5.75 | +483.76% | $427.71 | +0.24% | +483.52% |
| Sep 17, 2026 | $5.76 | +484.77% | $429.04 | +0.55% | +484.22% |
| Sep 16, 2026 | $5.73 | +481.73% | $430.43 | +0.88% | +480.85% |
| Sep 15, 2026 | $6.06 | +515.23% | $423.82 | -0.67% | +515.90% |
| Sep 14, 2026 | $6.07 | +516.24% | $425.49 | -0.28% | +516.52% |
| Sep 11, 2026 | $6.41 | +550.76% | $426.94 | +0.06% | +550.70% |
Page 1 of 17